EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSOKIG00005047593
Gene Symbol: MIF
1 Cross references
221 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSOKIG00005013433
Gene Symbol: MIF
3 Cross references
221 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOKIG00005013256
Gene Symbol: MST1R
3 Cross references
187 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSOKIG00005001449
Gene Symbol: LOC109898839
2 Cross references
181 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSOKIG00005029212
Gene Symbol: LOC109890865
2 Cross references
181 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSOKIG00005000607
Gene Symbol: LOC109890941
2 Cross references
187 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSOKIG00005031623
Gene Symbol: LOC109886525
2 Cross references
198 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSOKIG00005029417
Gene Symbol: LOC116360108
2 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSOKIG00005032212
Gene Symbol: MMP14A
1 Cross references
192 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSOKIG00005015923
Gene Symbol: MMP14A
1 Cross references
192 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSOKIG00005050833
Gene Symbol: MMP14B
1 Cross references
190 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOKIG00005002037
Gene Symbol: MMP2
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).